nach oben

Journal of Neurology

Erschienen in:

01.01.2010 | Original Communication

Characterization of functioning in multiple sclerosis using the ICF

verfasst von: Lisa Holper, Michaela Coenen, Andrea Weise, Gerold Stucki, Alarcos Cieza, Jürg Kesselring

Erschienen in: Journal of Neurology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to explore whether it is possible to describe based on the International Classification of Functioning, Disability and Health (ICF) relevant aspects of functioning and disability affected in multiple sclerosis (MS) as well as environmental factors relevant to persons with MS. The specific aim was to identify most relevant ‘Body functions’, ‘Body structures’, ‘Activities and participation’, as well as ‘Environmental factors’ in patients with MS using the ICF. Additionally, different MS forms were compared with respect to the identified problems. A multi-centre study was conducted in an empirical cross-sectional design. Data from 205 individuals with MS were collected in rehabilitation centres: disease related data, socio-demographic data, single interviews based on the Extended ICF Checklist and a patient questionnaire including ratings on general health and functioning status, Beck Depression Inventory II (BDI-II) and Comorbidity Questionnaire (SCQ). The 129 ICF categories identified represent a comprehensive classification of functioning in MS from the clinical perspective. Differences between MS forms were observed for several ICF categories, EDSS, general health and functioning status, but not for BDI and SCQ. The study showed that it is possible to describe based on the ICF the spectrum in functioning and disability affected in MS as well as environmental factors relevant to persons with MS.

Amato MP, Zipoli V, Portaccio E (2006) Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 245:41–46CrossRefPubMed

Avasarala J, Cross A, Trinkaus K (2003) Comparative assessment of yale single question and beck depression inventory scale in screening for depression in multiple sclerosis. Multiple Scler 9:307–310CrossRef

Beck A, Steer R, Brown G (1996) Manual for beck depression inventory-II—manual. The Psychological Corporation, San Antonio

Beck A, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychia 4:53–63

Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J, Myhr K (2008) Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 15:329–345CrossRef

Clingerman E, Stuifbergen A, Becker H (2004) The influence of resources on perceived functional limitations among women with multiple sclerosis. J Neurosci Nurs 36:312–321CrossRefPubMed

Ewert T, Fuessl M, Cieza A, Anderson C (2004) Identification of the most common problems in patients with chronic conditions using the ICF checklist. J Rehabil Med Suppl 44:22–29CrossRef

Flachenecker P, Rieckmann P (2004) Health outcome in multiple sclerosis. Curr Opin Neurol 17:257–261CrossRefPubMed

Fraser C, Polito S (2007) A comparative study of self-efficacy in men and women with multiple sclerosis. J Neurosci Nurs 39:102–106CrossRefPubMed

10.

Green G, Todd J, Pevalin D (2007) Biographical disruption associated with multiple sclerosis: using propensity scoring to assess the impact. Soc Sci Med 65:524–535CrossRefPubMed

11.

Hastie T, Tibshirani R, Friedman J (2008) The elements of statistical learning: data mining, inference, and prediction. New York

12.

Hautzinger M, Keller F, Kühner C (2006) BDI-II—beck depressions-inventar 2. Auflage Harcourt Test Services, Frankfurt/Main

13.

Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold S (2008) Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Multiple Scler 14:988–991CrossRef

14.

Johansson S, Ytterberg C, Claesson I, Lindberg J, Hillert J, Andresson M, Widén Holmqvist L, von Koch L (2007) High concurrent presence of disability in multiple sclerosis. J Neurol 254:767–773CrossRefPubMed

15.

Julian L, Merluzzi N, Mohr D (2007) The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis. Multiple Scler 13:81–86CrossRef

16.

Kesselring J, Beer S (2005) Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 4:643–652CrossRefPubMed

17.

Kira J, Tobimatsu S, Goto I, Hasuo K (1993) Primary progressive versus relapsing remitting multiple sclerosis in Japanese patients: a combined clinical, magnetic resonance imaging and multimodality evoked potential study. J Neurol Sci 117:179–185CrossRefPubMed

18.

Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B (2006) Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 77:918–926CrossRefPubMed

19.

Lobentanz I, Asenbaum S, Vaas K, Sauter C, Klösch G, Kollegger H, Kristoferitsch W, Zeitlhofer J (2004) Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatique and sleep quality. Acta Neurol Scand 110:6–13CrossRefPubMed

20.

MacAllister W, Krupp L (2005) Multiple sclerosis-related fatique. Phys Med Rehabil Clin N Am 16:483–502PubMed

21.

Marrow T (2007) The costs and consequences of multiple sclerosis relapses: a managed care perspective. J Neurol Sci 15:S39–S44CrossRef

22.

Nortvedt M, Riise T, Fruqård J, Mohn J, Bakke A, Skår A, Nyland H, Glad S, Myhr K (2007) Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Scler 13:106–112CrossRef

23.

Osborne T, Jensen M, Ehde D, Hanley M, Kraft G (2007) Psychological factors associated with pain intensity, pain-related interference, and psychological functioning in persons with multiple sclerosis and pain. Pain 127:52–62CrossRefPubMed

24.

Polman C, Reingold S, Edan G, Filippi M, Hartung H-P, Kappos L, Lublin F, Metz L, McFarland H, O’Connor P, Sandberg-Wollheim M, Thompson A, Weinshenker B, Wolinsky J (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58:840–846CrossRefPubMed

25.

Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G, Johnson K, Sibley W, Silberberg D, Tourtellotte W (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231CrossRefPubMed

26.

Potagas C, Giogkaraki E, Koutsis G, Mandellos D, Tsirempolou E, Sfagos C, Vassilopoulos D (2008) Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 267:100–106CrossRefPubMed

27.

Putzki N, Katsarava Z, Vago S, Diener H, Limmroth V (2008) Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. Eur Neurol 59:136–142CrossRefPubMed

28.

Rashid W, Hadjiprocopis A, Davies G, Griffin C, Chard D, Tiberio M, Altmann D, Wheeler-Kingshott C, Tozer D, Thompson A, Miller D (2008) Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging. J Neurol 255:390–397CrossRefPubMed

29.

Rot U, Mesec A (2006) Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis. Clin Neurol Neurosurg 108:271–274CrossRefPubMed

30.

Sá M (2007) Psychological aspects of multiple sclerosis. Clin Neurol Neurosurg (in press)

31.

Sangha O, Stucki G, Liang M, Fossel A, Katz J (2003) The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49:156–163CrossRefPubMed

32.

Simioni S, Ruffieux C, Bruggimann L, Annoni J, Schluep M (2007) Cognition, mood and fatigue in patients in the early stage of multiple sclerosis. Swiss Med Wkly 137:496–501PubMed

33.

Thompson A (2004) Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. Multiple Scler 10:S2–S7CrossRef

34.

Turpin K, Carroll L, Cassidy J, Hader W (2007) Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs. Multiple Scler 13:1038–1045CrossRef

35.

Ustun B, Chatterji S, Bickenbach J, Konstansjek N, Schneider M (2001) The World Health Classification, ICIDH-2 checklist 2.1a clinical form for international classification of functioning, disability and health. ICF, Geneva

36.

Vleugels L, Pfennings L, Pouwer F, Cohen L, Ketelaer P, Polman C, Lankhorst G, van der Ploeg H (1998) Psychological functioning in primary progressive versus secondary progressive multiple sclerosis. Br J Med Psychol 71:99–106PubMed

37.

WHO (2004) Atlas: country resources for neurological disorders. WHO, Geneva

38.

WHO (2001) International Classification of Functioning, Disability and Health: ICF. WHO, Geneva

39.

Yuan M, Lin Y (2006) Model selection and estimation in regression with grouped variables. J R Stat Soc B 68:49–67CrossRef

Titel: Characterization of functioning in multiple sclerosis using the ICF
verfasst von: Lisa Holper
Michaela Coenen
Andrea Weise
Gerold Stucki
Alarcos Cieza
Jürg Kesselring
Publikationsdatum: 01.01.2010
Verlag: D. Steinkopff-Verlag
Erschienen in: Journal of Neurology / Ausgabe 1/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-009-5282-4

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Brachial neuritis caused by varicella-zoster diagnosed by changes in brachial plexus on MRI

Flexion-induced cervical myelopathy associated with fewer elastic fibers and thickening in the posterior dura mater

Pravastatin and cognitive function in the elderly. Results of the PROSPER study

An evaluation of rating scales utilized for deep brain stimulation for dystonia

Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients